Eden Research plc (LON:EDEN – Get Free Report)’s stock price traded up 2.8% during mid-day trading on Wednesday after an insider bought additional shares in the company. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares were traded during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey bought 540,540 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Trading Up 2.8 %
The company has a debt-to-equity ratio of 1.25, a current ratio of 3.80 and a quick ratio of 2.42. The firm has a fifty day simple moving average of GBX 3.88 and a 200-day simple moving average of GBX 4.01. The firm has a market cap of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Recommended Stories
- Five stocks we like better than Eden Research
- How is Compound Interest Calculated?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Use Stock Screeners to Find Stocks
- What Does the Future Hold for Eli Lilly?
- Manufacturing Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.